TEACHERS ADVISORS, LLC - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 105 filers reported holding ARATANA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$346,000
-41.3%
96,0800.0%0.00%
-100.0%
Q4 2018$589,000
-29.5%
96,080
-32.8%
0.00%0.0%
Q3 2018$836,000
+172.3%
143,080
+98.1%
0.00%
Q2 2018$307,000
-3.8%
72,2440.0%0.00%
Q1 2018$319,000
-16.1%
72,2440.0%0.00%
Q4 2017$380,000
-14.2%
72,2440.0%0.00%
-100.0%
Q3 2017$443,000
-15.1%
72,2440.0%0.00%0.0%
Q2 2017$522,000
+83.2%
72,244
+34.5%
0.00%
Q1 2017$285,000
-21.5%
53,718
+6.3%
0.00%
-100.0%
Q4 2016$363,000
-23.3%
50,5450.0%0.00%0.0%
Q3 2016$473,000
+48.3%
50,5450.0%0.00%0.0%
Q2 2016$319,000
+9.6%
50,545
-4.1%
0.00%0.0%
Q1 2016$291,000
+19.3%
52,709
+20.5%
0.00%
Q4 2015$244,000
-62.5%
43,753
-43.1%
0.00%
-100.0%
Q3 2015$651,000
-43.9%
76,896
+0.2%
0.00%
-50.0%
Q2 2015$1,161,000
-1.8%
76,770
+4.0%
0.00%0.0%
Q1 2015$1,182,000
+44.9%
73,813
+61.3%
0.00%0.0%
Q4 2014$816,000
+77.4%
45,7740.0%0.00%
+100.0%
Q3 2014$460,000
-15.0%
45,774
+32.1%
0.00%0.0%
Q2 2014$541,000
+128.3%
34,653
+170.9%
0.00%0.0%
Q1 2014$237,000
+100.8%
12,790
+107.3%
0.00%
Q4 2013$118,000
+16.8%
6,1700.0%0.00%
Q3 2013$101,0006,1700.00%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
March Altus Capital Management LP 218,515$2,045,00012.79%
Broadfin Capital, LLC 3,085,979$28,885,0002.59%
First Light Asset Management, LLC 467,743$4,378,0001.88%
AWM Investment Company, Inc. 1,005,000$9,407,0001.72%
MPM ASSET MANAGEMENT LLC 250,000$2,340,0000.77%
Grandeur Peak Global Advisors, LLC 394,450$3,692,0000.72%
TURNER INVESTMENTS LLC 208,660$1,953,0000.65%
WALL STREET ASSOCIATES 197,400$1,848,0000.63%
TFS CAPITAL LLC 192,848$1,805,0000.43%
GENERAL AMERICAN INVESTORS CO INC 412,101$3,857,0000.39%
View complete list of ARATANA THERAPEUTICS INC shareholders